Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 19/20 | 0.68 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.68 |
| ▸ | HDAC3 | O15379 | 8/20 | 0.68 |
| ▸ | NCOR2 | Q9Y618 | 5/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.58 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.58 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.58 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.58 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8401704 | 0.85 | HDAC1 (0.89) | HDAC1HDAC2HDAC3NCOR2MAPK1 | |
| SCHEMBL22811714 | 0.83 | HDAC1 (0.73) | HDAC1HDAC2HDAC3NCOR2MAPK1 | |
| SCHEMBL10373334 | 0.81 | HDAC1 (0.71) | HDAC1HDAC2HDAC3NCOR2MAPK1 | |
| SCHEMBL8349329 | 0.81 | HDAC1 (0.70) | HDAC1HDAC2HDAC3NCOR2MAPK1 | |
| Dinaline SCHEMBL29354254 | 0.80 | HDAC1 (0.79) | HDAC1HDAC2HDAC3NCOR2MAPK1 | |
| SCHEMBL1060598 | 0.80 | HDAC1 (0.79) | HDAC1HDAC2HDAC3NCOR2MAPK1 | |
| Dinaline SCHEMBL93636 | 0.80 | HDAC1 (0.79) | HDAC1HDAC2HDAC3NCOR2MAPK1 | |
| SCHEMBL30363156 | 0.80 | HDAC1 (1.00) | HDAC1HDAC2HDAC3NCOR2MAPK1 | |
| SCHEMBL407834 | 0.80 | HDAC1 (1.00) | HDAC1HDAC2HDAC3NCOR2MAPK1 | |
| Tacedinaline SCHEMBL29482198 | 0.80 | HDAC1 (0.74) | HDAC1HDAC2HDAC3NCOR2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5137918-A | Anticancer agent | GOEDECKE AKTIENGESELLSCHAFT (DE) | 1992-08-11 | — | — | US | claimed |
| EP-0242851-A1 | N-(2'-aminophenyl)-benzamide derivatives, process for their manufacture and their application in the treatment of neoplastic illness | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1987-10-28 | — | — | EP | claimed |
| WO-2023284651-A1 | N-(2-AMINOPHENYL)BENZAMIDE COMPOUND AND APPLICATION THEREOF | 南京明德新药研发有限公司 | 2023-01-19 | — | — | WO | disclosed |
| WO-2021148811-A1 | HDAC DEGRADER | UNIVERSITY OF LEICESTER (GB) | 2021-07-29 | — | — | WO | disclosed |
| WO-2009076234-A2 | SYNTHESIS METHODS OF HISTONE DEACETYLASE INHIBITORS (HDACIS) | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2009-06-18 | — | — | WO | disclosed |
| US-5137918-A | Anticancer agent | GOEDECKE AKTIENGESELLSCHAFT (DE) | 1992-08-11 | — | — | US | disclosed |
| EP-0242851-A1 | N-(2'-aminophenyl)-benzamide derivatives, process for their manufacture and their application in the treatment of neoplastic illness | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1987-10-28 | — | — | EP | disclosed |